Back to TMO
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA → TMO
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA TMO Position History
Thermo Fisher Scientific Inc. • Healthcare
Quarters held
16
Latest value
$536K
Q3 2026
Peak value
$335.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $335.7M |
| Q4 2025 | $65K |
| Q4 2025 | $265K |
| Q4 2025 | $636K |
| Q1 2026 | $262.9M |
| Q1 2026 | $52K |
| Q1 2026 | $211K |
| Q1 2026 | $406K |
| Q2 2026 | $245.7M |
| Q2 2026 | $52K |
| Q2 2026 | $213K |
| Q2 2026 | $411K |
| Q3 2026 | $305.8M |
| Q3 2026 | $70K |
| Q3 2026 | $287K |
| Q3 2026 | $536K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $536K | 794 | — | — |
| Q3 2026 | $287K | 425 | — | — |
| Q3 2026 | $70K | 104 | — | — |
| Q3 2026 | $305.8M | 453.0K | — | — |
| Q2 2026 | $411K | 819 | — | — |
| Q2 2026 | $213K | 425 | — | — |
| Q2 2026 | $52K | 104 | — | — |
| Q2 2026 | $245.7M | 490.1K | — | — |
| Q1 2026 | $406K | 819 | — | — |
| Q1 2026 | $211K | 425 | — | — |
| Q1 2026 | $52K | 104 | — | — |
| Q1 2026 | $262.9M | 529.9K | — | — |
| Q4 2025 | $636K | 1.0K | — | — |
| Q4 2025 | $265K | 425 | — | — |
| Q4 2025 | $65K | 104 | — | — |
| Q4 2025 | $335.7M | 538.1K | — | — |
Other funds holding TMO
$17.6B
$15.8B
$14.7B
$10.1B
$9.6B
$9.6B